image

image
image
image
image
image
image
image

Your frank and considered evaluation will be helpful in improving our CME activity.

Circle your rating on the following statements using this scale: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

  1. To what extent did the objectives relate to the overall goal/purpose of this activity?

    (Poor)  1image 2image 3image 4image 5  (Excellent)
  2. To what extent have you achieved each objective of this activity?

    Objective 1: Understand the basic principles of immunology, and strategies of cancer Immunotherapy.

    (Poor)  1image 2image 3image 4image 5  (Excellent)


    Objective 2: Understand the development and clinical applications of monoclonal antibodies.

    (Poor)  1image 2image 3image 4image 5  (Excellent)


    Objective 3: Identify cytokines that play important roles in cancer Immunotherapy.

    (Poor)  1image 2image 3image 4image 5  (Excellent)


    Objective 4: Discuss the development of cancer vaccines - obstacles, areas for further exploration, and potential applications.

    (Poor)  1image 2image 3image 4image 5  (Excellent)
  3. How do you rate the information presented in this activity?

    _____ Superior _____ Satisfactory _____ Unsatisfactory
  4. CME activities must be free of commercial bias for or against any product. In your opinion were the authors biased in their discussion of any commercial product?

    _____ Yes _____ No
  5. Please describe any changes you plan to make in your clinical practice based on the information presented in this activity.

  6. Any comments/suggestions for future educational activities?

  7. Would you recommend this material to your colleagues?

    _____ Yes _____ No
  8. I have read the presentations and completed the self-assessment quiz and evaluation in _____ hour(s).

 

Please print out and mail the completed evaluation sheet to:

CCME
Albert Einstein College of Medicine
3301 Bainbridge Avenue
Bronx, NY 10467

For more information, call the Center for Continuing Medical Education at (718) 920-6674.